Galway-Roscommon Mental Health Services, University Hospital Galway, Galway, Ireland.
School of Medicine, National University of Ireland Galway, Galway, Ireland.
Ir J Psychol Med. 2021 Jun;38(2):123-131. doi: 10.1017/ipm.2020.75. Epub 2020 Jun 8.
To examine the psychological and social impact of the COVID-19 pandemic on patients with established anxiety disorders during a period of stringent mandated social restrictions.
Semi-structured interviews were conducted with 30 individuals attending the Galway-Roscommon Mental Health Services with an International Classification of Diseases diagnosis of an anxiety disorder to determine the impact of the COVID-19 restrictions on anxiety and mood symptoms, social and occupational functioning and quality of life.
Twelve (40.0%) participants described COVID-19 restrictions as having a deleterious impact on their anxiety symptoms. Likert scale measurements noted that the greatest impact of COVID-19 related to social functioning (mean = 4.5, SD = 2.9), with a modest deleterious effect on anxiety symptoms noted (mean = 3.8, SD = 2.9). Clinician rated data noted that 8 (26.7%) participants had disimproved and 14 (46.7%) participants had improved since their previous clinical review, prior to commencement of COVID-19 restrictions. Conditions associated with no 'trigger', such as generalised anxiety disorder, demonstrated a non-significant increase in anxiety symptoms compared to conditions with a 'trigger', such as obsessive compulsive disorder. Psychiatric or physical comorbidity did not substantially impact on symptomatology secondary to COVID-19 mandated restrictions.
The psychological and social impact of COVID-19 restrictions on individuals with pre-existing anxiety disorders has been modest with only minimal increases in symptomatology or social impairment noted.
在严格执行强制性社会限制措施期间,研究 COVID-19 大流行对已确诊焦虑障碍患者的心理和社会影响。
对 30 名在戈尔韦-罗森诺心理健康服务中心就诊的患有国际疾病分类诊断的焦虑障碍的个体进行半结构化访谈,以确定 COVID-19 限制对焦虑和情绪症状、社交和职业功能以及生活质量的影响。
12 名(40.0%)参与者表示 COVID-19 限制对他们的焦虑症状有不良影响。李克特量表测量指出,COVID-19 相关的最大影响是社交功能(均值=4.5,标准差=2.9),焦虑症状有适度的不良影响(均值=3.8,标准差=2.9)。临床医生评定的数据指出,自 COVID-19 限制开始前的上次临床评估以来,8 名(26.7%)参与者的病情恶化,14 名(46.7%)参与者的病情改善。与有“触发因素”的疾病(如强迫症)相比,没有“触发因素”的疾病(如广泛性焦虑症)的焦虑症状呈非显著增加。由于 COVID-19 强制限制而导致的精神病或身体合并症并未对症状学产生重大影响。
COVID-19 限制对患有先前存在的焦虑障碍的个体的心理和社会影响适度,仅注意到症状学或社会障碍有轻微增加。